Publications by authors named "Katia Bifulco"

Claim this Profile
R
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.
Maria Vincenza Carriero, Katia Bifulco, Vincenzo Ingangi, Susan Costantini, Giovanni Botti

Sci Rep· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.
Vincenzo Ingangi, Katia Bifulco, Ali Munaim Yousif, Concetta Ragone, Maria Letizia Motti

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.
Vashisht G. Y. Nanda, Weiyi Peng, Patrick Hwu, Michael A. Davies, Gennaro Ciliberto, Katia Bifulco

J Transl Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.
Ali Munaim Yousif, Michele Minopoli, Katia Bifulco, Vincenzo Ingangi, Gioconda Di Carluccio

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.
Maria Rita Milone, Biagio Pucci, Katia Bifulco, Federica Iannelli, Rita Lombardi

Oncotarget· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.
Katia Bifulco, Giuseppina Votta, Vincenzo Ingangi, Gioconda Di Carluccio, Domenica Rea

Oncotarget· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UPARANT: a urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency.
Maria Vincenza Carriero, Katia Bifulco, Michele Minopoli, Liliana Lista, Ornella Maglio

Mol Cancer Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting.
Katia Bifulco, Immacolata Longanesi-Cattani, Eleonora Liguori, Claudio Arra, Domenica Rea

Mol Cancer Ther· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.
Katia Bifulco, Immacolata Longanesi-Cattani, Paola Franco, Vincenzo Pavone, Pietro Mugione

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.
Nunzia Montuori, Katia Bifulco, Maria Vincenza Carriero, Claudio La Penna, Valeria Visconte

Cell Mol Life Sci· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization.
Katia Bifulco, Immacolata Longanesi-Cattani, Maria Teresa Masucci, Annarosaria De Chiara, Flavio Fazioli

Sarcoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.
Maria Vincenza Carriero, Immacolata Longanesi-Cattani, Katia Bifulco, Ornella Maglio, Liliana Lista

Mol Cancer Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells.
Adone Baroni, Giovanna Donnarumma, Iole Paoletti, Immacolata Longanesi-Cattani, Katia Bifulco

Peptides· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure, function and antagonists of urokinase-type plasminogen activator.
Maria Vincenza Carriero, Paola Franco, Imma Vocca, Daniela Alfano, Immacolata Longanesi-Cattani, Katia Bifulco

Front Biosci (Landmark Ed)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell invasiveness in sarcomas: a possibly useful clinical correlation.
Katia Bifulco, Annarosaria De Chiara, Flavio Fazioli, Immacolata Longanesi-Cattani, Anna Rita Cantelmo

Tumori· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor.
Katia Bifulco, Immacolata Longanesi-Cattani, Lucia Gargiulo, Ornella Maglio, Mauro Cataldi

FEBS Lett· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
Lucia Gargiulo, Immacolata Longanesi-Cattani, Katia Bifulco, Paola Franco, Rosanna Raiola

J Biol Chem· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis